Portulaca oleracea L. Repairs the Skin Barrier and Alleviates Atopic Dermatitis by Targeting Lipid Metabolism to Regulate the JAK1/STAT3 Signaling Pathway and Downregulate Th2 Inflammatory Cytokines
Background: Portulaca oleracea L. (POL) has anti-inflammatory and immunomodulatory activities, but its mechanism against atopic dermatitis (AD) remains incompletely understood. Methods: 2,4-dinitrofluorobenzene (DNFB)-induced AD mice were treated orally with POL or dexamethasone for 14 days. We evaluated skin lesions,...